遇见数据集

Unit survey, elderly care - Current routine exists for how drug reviews should be carried out and how collaboration should take place together with the individual, the doctor, the nurse responsible for special housing, elderly care, proportion (%)

收藏
data.europa2024-10-08 更新2025-04-19 收录
官方服务:

资源简介:

For unit level, the value is given as "Yes, for both" = 2, "Yes, for simple" & "Yes, for deepened" = 1 and "No" = 0 while at municipality level it is only given as a proportion (%) of units where the answer is "Yes, for both". The key figure is based on the following survey questions: "Have you, on 1 March, written and at management level decided routines for how simple and in-depth drug reviews should be carried out in collaboration with the region?", "Does the routine describe how collaboration at drug reviews should take place together with the individual, the doctor, the nurse and the home care staff at the unit?" and "Have you at any time during the last year (12 months) followed up the routine?". A simple drug review shall be offered to people 75 years of age and older with at least five drugs in accordance with the National Board of Health and Welfare's regulations and general advice HSLF-FS 2017:37. An in-depth drug review shall be offered to people who, after a simple drug review, have persistent drug-related problems or where there are suspicions of the presence of such problems. The doctor is responsible for following up, updating and reconsidering the goals of the treatment that resulted from the drug review.

在单位层级,赋值规则如下:「两者均适用」记为2,「仅适用于简易审查」与「仅适用于深化审查」记为1,「不适用」记为0;而在市政层级,仅以回答「两者均适用」的单位占比(%)来呈现核心指标。本数据集的核心指标基于以下三项调研问题:1. 您是否已于3月1日制定并经管理层审批,明确了与区域协作开展简易及深化药物审查的相关流程?2. 该流程是否规定了在单位层面如何与服务对象、医师、护士及居家护理人员协作开展药物审查?3. 您是否在过去一年(12个月)内对该流程进行过跟进?根据国家卫生与福利委员会(National Board of Health and Welfare)的规范及通用指南HSLF-FS 2017:37,75岁及以上且同时服用至少5种药物的人群,需为其提供简易药物审查服务。经简易药物审查后存在持续性药物相关问题,或疑似存在此类问题的人群,需为其提供深化药物审查服务。医师负责跟进、更新并重新审视由药物审查所确定的治疗目标。

二维码
社区交流群
二维码
科研交流群
商业服务